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Cambridge, Mass
Objective: After endovascular aortic aneurysm repair (EVAR), the Society for Vascular Surgery recommends a computed to-
mography (CT) scan#30 days, followed by annual imaging.We sought to describe long-term adherence to surveillance guidelines
among United States Medicare beneﬁciaries and determine patient and hospital factors associated with incomplete surveillance.
Methods: We analyzed fee-for-service Medicare claims for patients receiving EVAR from 2002 to 2005 and collected all
relevant postoperative imaging through 2011. Additional data included patient comorbidities and demographics, yearly
hospital volume of abdominal aortic aneurysm repair, and Medicaid eligibility. Allowing a grace period of 3 months,
complete surveillance was deﬁned as at least one CT or ultrasound assessment every 15 months after EVAR. Incomplete
surveillance was categorized as gaps for intervals >15 months between consecutive images as or lost to follow-up if
>15 months elapsed after the last imaging.
Results: Our cohort comprised 9695 patients. Median follow-up duration was 6.1 years. A CT scan #30 days of EVAR
was performed in 3085 (31.8%) patients and #60 days in 60.8%. The median time to the postoperative CT was 38 days
(interquartile range, 25-98 days). Complete surveillance was observed in 4169 patients (43.0%). For this group, the mean
follow-up time was shorter than for those with incomplete surveillance (3.4 6 2.74 vs 6.5 6 2.1 years; P < .001). Among
those with incomplete surveillance, follow-up became incomplete at 3.3 6 1.9 years, with 57.6% lost to follow-up, 64.1%
with gaps in follow-up (mean gap length, 760 6 325 days), and 37.6% with both. A multivariable analysis showed
incomplete surveillance was independently associated with Medicaid eligibility (hazard ratio [HR], 1.42; 95% conﬁdence
interval [CI], 1.29-1.55; P < .001), low-volume hospitals (HR, 1.12; 95% CI, 1.05-1.20; P < .001), and ruptured
abdominal aortic aneurysm (HR, 1.51; 95% CI, 1.24-1.84; P < .001).
Conclusions: Postoperative imaging after EVAR is highly variable, and less than half of patients meet current surveillance
guidelines. Additional studies are necessary to determine if variability in postoperative surveillance affects long-term
outcomes. (J Vasc Surg 2015;61:23-7.)The treatment of abdominal aortic aneurysms (AAAs)
has shifted from open surgical repair to endovascular aortic
aneurysm repair (EVAR) in recent years.1 Although EVAR
has been associated with greater perioperative survival
compared with open surgical repair, signiﬁcant concerns
remain regarding the long-term durability of the repair.2-4
Persistent aneurysm enlargement and potential rupture can
occur after EVAR, and patients are therefore advised to un-
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://dx.doi.org/10.1016/j.jvs.2014.07.003Vascular Surgery (SVS) recommends computed tomography
(CT) scanning at 1 and 12 months during the ﬁrst postoper-
ative year, with an additional CT at 6 months if an abnormal-
ity is detected at the ﬁrst month. After the ﬁrst year, CT
scanning is recommended every 12months, with the alterna-
tive option of ultrasound imaging if no abnormality was
detected during the ﬁrst year.5
Notwithstanding these guidelines, several single-
institutional studies suggest that only a minority of patients
receive the recommended life-long surveillance after
EVAR.6-8 These studies, however, may underestimate the
true adherence to surveillance guidelines because patients
may relocate or receive surveillance imaging from other hos-
pitals. We used Medicare claims data to describe long-term
adherence to SVS surveillance guidelines in actual practice
and determine patient and hospital-level factors associated
with complete and incomplete surveillance.
METHODS
This study was approved by the Stanford University
School of Medicine Institutional Review Board, with a
waiver of consent because the study was retrospective
and the data used did not contain patient names or other
contact information.23
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for-service claims data from 2002 to 2011. The Medical
Provider and Analysis Review (MedPAR, part A) ﬁles and
physician Carrier (part B) ﬁles were used to identify inpa-
tient claims by hospitalizations and physicians services that
were billed, respectively. All diagnoses and hospital pro-
cedures from the MedPAR (part A) ﬁles were identiﬁed
using the International Classiﬁcation of Diseases, Ninth
Revision, Clinical Modiﬁcation (ICD-9-CM) codes found
as part of each inpatient claim. Similarly, Current Proce-
dure Terminology (CPT) codes (American Medical Asso-
ciation, Chicago, Ill) were used to identify physician
procedures from the Carrier (part B) ﬁles. The Medicare
denominator and beneﬁciary summary ﬁles were used to
collect demographic, Medicare enrollment information,
and mortality data.
Patient events. Our cohort consisted of patients who
underwent AAA repair with EVAR between January 1,
2002, and December 31, 2005, without perioperative
mortality, deﬁned as death at discharge or #30 days of sur-
gery. Patients were identiﬁed using an ICD-9-CM diag-
nosis code for intact (441.4, 441.9) or ruptured (441.3,
441.5) AAA, as well as an ICD-9-CM procedure code for
AAA repair (38.34, 38.44, 38.64, 38.92, 39.71). The date
of AAA repair was recorded as the index date.
Patients aged <65 years on the index date were
excluded. Also excluded were patients with enrollment in
a health maintenance organization (HMO) or those with
incomplete Medicare part A or part B coverage because
claims for these patients might be incomplete. We deﬁned
the follow-up period as the duration between the date of
the surgery and the date of censoring: HMO enrollment,
incomplete Medicare part A or part B coverage, or death
at any time during the follow-up.
During the follow-up period, all postoperative imaging
data were collected using CPT codes for ultrasound imag-
ing (76770, 76775, 93975, 93976, 93978, 93979) and
CT (72191, 72192, 72193, 72194, 74150, 74151,
74152, 74153, 74154, 74155, 74156, 74157, 74158,
74159, 74160, 74161, 74162, 74163, 74164, 74165,
74166, 74167, 74168, 74169, 74170, 74171, 74172,
74173, 74174, 74175, 74176, 74177, 74178, 74261,
74262, 74263, 75635) of the abdomen. Multiple codes
of the same imaging modality on the same date were
counted as one postoperative surveillance imaging
examination.
Allowing a grace period of 3 months, we deﬁned com-
plete surveillance as one imaging event #15 months of
repair and at least one imaging event every 15 months
thereafter. We categorized incomplete surveillance as a
gap in surveillance if the interval between images was
>15 months, and loss to follow-up if the censor date was
>15 months from the date of the last imaging event.
Other measures. The Medicare denominator and
beneﬁciary summary ﬁles were used to record age, sex,
race, and Medicaid eligibility status. The U.S. Department
of Agriculture census-based Rural Urban Commuting Area
(RUCA) codes were used to categorize patients’ residenceas urban or rural, as previously described.9 Metropolitan
areas had a population of >50,000 and included RUCA
codes 1, 2, 3, 4.1, 7.1, 8.1, and 10.1. Nonmetropolitan
areas were deﬁned as a population of <50,000 and
included RUCA codes 4, 5, 6, 7, 7.2, 7.3, 7.4, 8, 8.2 8.3,
8.4, 9, 9.1, 9.2, 10, 10.2, 10.3, and 10.5.
Comorbidity was estimated as described by Elixhauser
et al.10 Hospital annual AAA repair volumes were con-
verted to a ﬁve-level ordinal categoric variable. Hospitals
in the lowest quintile (median, ﬁve EVARs per year)
were deﬁned as low-volume hospitals, and those in the
highest quintile (median, 63 EVARs per year) were deﬁned
as high-volume hospitals.
Statistical analysis. Categoric variables, such as the
characteristics of patients with complete and incomplete
surveillance, were analyzed using a c2 test, and continuous
variables were analyzed using a t-test for normally distrib-
uted data or a Wilcoxon signed rank test for nonparametric
data. Multivariable logistic and Cox regression modeling
controlling for age, sex, race, Medicaid eligibility, residen-
tial status, hospital volume, ruptured AAA (rAAA), and
pre-existing comorbidities were used to determine pre-
dictors of postoperative CT, complete surveillance, and loss
to follow-up.
All statistical analyses with P values of<.05 were consid-
ered signiﬁcant. Statistical analyses were performed using
SAS 9.1.3 software (SAS Institute Inc, Cary, NC) for data
extraction and management and using STATA 13.0 soft-
ware (StataCorp LP, College Station, Tex) for analysis.
RESULTS
A total of 23,964 patients underwent AAA repair be-
tween January 1, 2002, and December 31, 2005, among
which 23,165 (96.7%) were aged $65 years during the
year of repair. Among these, 22,399 (96.6%) had complete
fee-for-service Medicare part A and part B coverage during
year of repair. From this subpopulation, 9975 (47.2%) un-
derwent EVAR, and 9695 EVAR patients (97.2%) survived
the initial hospital stay and deﬁned our cohort. Mean
follow-up duration was 5.2 6 2.9 years (median, 6.1 years;
interquartile range, 2.6-7.4 years).
Of our cohort, 497 (5.13%) patients received no
follow-up imaging. The ﬁrst postoperative CT was ob-
tained #30 days in 31.8% of patients, #45 days in
53.3%, and #60 days in 60.8%. The mean time to a post-
operative CT was 154 6 371 days (median, 38 days; inter-
quartile range, 25-98 days; Fig 1). Among those with a
30-day CT, 23.0% received the CT scan during the index
hospital stay.
Complete surveillance was observed in 4169 patients
(43.0%; Table I). No signiﬁcant difference was observed
in age, sex, race, or Medicaid eligibility between patients
with complete and incomplete surveillance. Patients with
congestive heart failure were more likely to have complete
surveillance (53.3% vs 46.7%; P < .001), as were those with
renal failure (52.1% vs 47.9%; P < .001), lymphoma (63.3%
vs 36.7%; P ¼ .004), metastatic cancer (78.2% vs 23.8%;
P < .001), and solid tumors (53.6% vs 46.4%; P < .001).
Table I. Characteristics of patients with complete and
incomplete surveillance
Variables
Complete
(n ¼ 4169)
Incomplete
(n ¼ 5526) P value
Age at repair,
mean 6 SD, years
76.4 6 6.32 76.2 6 6.25 .10
Sex, % .16
Male 43.3 56.7
Female 41.4 58.6
Race, % .09
White 42.8 57.2
Black 48.8 51.2
Other 42.2 57.8
Medicaid eligible, % .37
Yes 41.6 58.4
No 43.2 56.9
Residence, % .05
Urban 43.7 56.3
Small-town 40.3 59.7
Rural 42.0 58.0
Hospital volume,a % <.001
High 19.5 17.1
Medium 59.7 59.3
Low 20.8 23.6
Comorbidities, %
Valvular disease 46.1 53.9 .12
Congestive heart
failure
53.3 46.7 <.001
Peripheral vascular
disease
44.5 55.5 .04
Hypertension 42.6 57.4 .25
Diabetes mellitus 45.3 54.7 .07
Pulmonary disease 46.2 53.8 <.001
Renal failure 52.1 47.9 <.001
Lymphoma 63.3 36.7 .01
Metastatic cancer 78.2 23.8 <.001
Solid tumor 53.6 46.4 <.001
SD, Standard deviation.
aMedian fee-for-service Medicare endovascular aortic aneurysm repair
(EVAR) yearly case volume was 5 for low-volume hospitals (range, 1-7), 20
for medium-volume hospitals (range, 8-34), and 63 for high-volume hos-
pitals (range, 35-122).
Fig 2. Distribution of time to incomplete follow-up.
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Fig 1. Distribution of time to the ﬁrst postoperative computed
tomography (CT) scan.
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incomplete surveillance (46.2% vs 53.8%; P < .001).
Of those with incomplete surveillance, 42.5% had sur-
veillance gaps, 36.0% were lost to follow-up, and 21.5%
had gaps and were also lost to follow-up. Among thosewith incomplete surveillance, surveillance became incom-
plete at an average of 3.3 6 1.9 years (Fig 2). In addition,
total follow-up was shorter for those with complete surveil-
lance than for those with incomplete surveillance (3.4 6
2.7 vs 6.5 6 2.1 years; P < .001). Patients with at least
one gap in follow-up had a mean time of 3.1 6 1.6 years
until occurrence of the ﬁrst gap. Patients were lost to
follow-up at a mean of 4.6 6 2.4 years after EVAR.
A multivariable Cox regression model showed incom-
plete surveillance was independently associated with
increasing age (hazard ratio [HR], 1.02; 95% conﬁdence
interval [CI], 1.01-1.02; P < .001), Medicaid eligibility
(HR, 1.42; 95% CI, 1.29-1.55; P < .001), low-volume
hospitals (HR, 1.12; 95% CI, 1.05-1.20; P < .001),
rAAA (HR, 1.51; 95% CI, 1.24-1.84; P < .001), and
comorbidities that might also require ongoing care
(Table II). Additional analysis on loss to follow-up showed
that after adjusting for patient factors, loss to follow-up was
independently associated with increasing age (HR, 1.04;
95% CI, 1.03-1.04; P < .001), Medicaid eligibility (HR,
1.47; 95% CI, 1.30-1.65; P < .001), low-volume hospitals
(HR, 1.16; 95% CI, 1.06-1.26; P < .001), and rAAA (HR,
1.63; 95% CI, 1.29-2.07; P < .001).
In a multivariable logistic regression model, after
adjusting for patient factors, high-volume hospitals were
more likely to perform the ﬁrst postoperative CT scan
#30 days (odds ratio, 1.42; 95% CI, 1.27-1.59; P <
.001), whereas low-volume hospitals were less likely to
perform the scan within the recommended interval (odds
ratio, 0.85; 95% CI, 0.76-0.95; P ¼ .003).
DISCUSSION
We believe this is the ﬁrst study to investigate adherence
to recommended postoperative surveillance guidelines after
EVAR in actual practice.We found thatmost patients under-
going EVAR do not receive adequate surveillance as deﬁned
by the SVS. Our results showed that 5% of patients received
no follow-up imaging after EVAR, w33% were lost to
follow-up, and 57% received incomplete surveillance. A
main strength of our study is that it captures all surveillance
Table II. Multivariable Cox regression model for
incomplete surveillance
Factor HR (95% CI) P value
Age 1.02 (1.01-1.02) <.001
Male sex 1.02 (0.95-1.10) .540
Race
White (reference)
Black 1.10 (0.94-1.29) .230
Other 1.12 (0.96-1.32) .160
Medicaid eligibility 1.42 (1.29-1.55) <.001
Hospital volumea
Medium (reference)
Low 1.12 (1.05-1.20) <.001
High 0.94 (0.88-1.01) .110
rAAA 1.51 (1.24-1.84) <.001
Congestive heart failure 1.06 (0.96-1.18) .240
Neurologic 1.46 (1.25-1.87) <.001
Chronic lung 1.08 (1.02-1.15) .010
Renal failure 1.36 (1.16-1.59) <.001
Fluid and electrolyte disorders 1.12 (1.00-1.26) .050
Blood loss anemia 1.56 (1.20-2.03) <.001
Deﬁciency anemia 1.08 (0.95-1.23) .240
Alcohol abuse 1.52 (1.12-2.06) .010
Psychoses 1.49 (1.01-2.19) .040
Coagulopathy 1.19 (1.00-1.40) .050
CI, Conﬁdence interval; HR, hazard ratio, rAAA, ruptured abdominal
aortic aneurysm.
aMedian fee-for-service Medicare endovascular aortic aneurysm repair
(EVAR) yearly case volume was 5 for low-volume hospitals (range, 1-7), 20
for medium-volume hospitals (range, 8-34), and 63 for high-volume hos-
pitals (range, 35-122).
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and therefore more accurately measures actual practice and
adherence to SVS postoperative surveillance guidelines.
Our ﬁndings contrast with a single-institution study by
Kret et al6 that reported no postoperative imaging in 11%
and loss to follow-up in 56% of patients. Such single-
institution studies are limited because patients can relocate
or receive surveillance imaging from other hospitals, thus
resulting in undercapture of postoperative surveillance
events. Similarly, we found lower rates of incomplete surveil-
lance compared with studies that analyzed data from a regis-
try as part of a clinical trial.8 These ﬁndings reinforce these
investigators’ conclusions that the external validity of such
clinical trial studies for surveillance guidelines may be ques-
tionable because they do not reﬂect actual practice.7
Understanding the barriers to appropriate surveillance
after EVAR is paramount to offering EVAR to the right pa-
tients.7 The SVS guidelines recommend that patients at risk
for poor compliance with postoperative surveillance be
identiﬁed and advised against EVAR for AAA repair. We
have found that hospital-level factors, previously unidenti-
ﬁed, may be more important in predicting incomplete sur-
veillance. We found that undergoing EVAR at a hospital
with a high AAA volume was independently associated
with complete surveillance, whereas undergoing EVAR at
a low-volume hospital was associated with loss to follow-
up and incomplete surveillance.
Previously, Sarangarm et al11 hypothesized that the Vet-
erans Affairs effectively maintains excellent postoperativefollow-up with patients after EVAR because of its rigorous
methods such as electronic appointment tracking and
travel vouchers. Thus, it is possible that hospitals with bet-
ter care coordination and abundant resources, such as
high-volume centers, are able to maintain better follow-
up with patients and encourage adequate surveillance after
EVAR.6 Our study is the ﬁrst to show that hospital-level
factors are strong predictors of completeness of surveil-
lance after EVAR. Our data help support previous litera-
ture that performing EVAR at high-volume centers yields
better outcomes.12,13
Our examination of geographic factors found that hav-
ing a rural or small-town residence impeded receiving com-
plete surveillance. These ﬁndings are consistent with
previously published studies that evaluated the association
of the distance of a patient’s residence from the hospital
and the likelihood of follow-up after EVAR. Although Sar-
angarm et al11 hypothesized that patients who lived close
(<100 miles from hospital) would have better compliance,
they found that patients who lived near and far both had a
similar length of follow-up. Similarly, Kret et al6 also
grouped patients into three categories by distance from
hospital (#60 miles, 60-120 miles, and >120 miles) and
found that median follow-up time did not differ signiﬁ-
cantly across the groups (P ¼ .52). Moreover, because rural
patients have been shown to be more likely to have an
EVAR at a high-volume hospital,9 this trend may wash
out the independent effect of patients’ rural and small-
town residence on completeness of surveillance. Thus,
taken together, geographic factors may not be contributing
to the completeness of surveillance.
In addition to geographic and hospital-level factors, we
found that having an rAAA was independently associated
with loss to follow-up and a trending independent associa-
tion with incomplete surveillance (Table II). We hypothesize
that because patients with poor preoperative surveillance are
more likely to present with an rAAA,14 these same patients
may be at risk for gaps in postoperative surveillance as well.
Some studies have suggested that EVAR for rAAA is associ-
ated with improved survival,15,16 whereas others have not
shown a reduction in early mortality.17,18 Nevertheless,
developing systems of postoperative care to address the
needs of this speciﬁc population may be important.
We found that a variety of preoperative comorbidities,
such as congestive heart failure, chronic lung disease, renal
failure, and cancer, were independently associated with
complete surveillance. We hypothesize that patients with
other medical conditions requiring ongoing care are
more likely to return for follow-up for their chronic dis-
eases and, thus, may be more likely to receive follow-up im-
aging for their EVAR. This is especially true for patients
with cancer, because they may have received imaging
primarily for reasons other than their EVAR. These obser-
vations contrast with other studies6 that found no associa-
tion between patient demographics or comorbidities and
completeness of surveillance and are consistent with inves-
tigations by Leurs et al8 that found hyperlipidemia and
smoking status were predictive of better follow-up.
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nature of administrative data. As with all studies using
administrative data, we were unable to collect clinical infor-
mation, such as presence or absence of endoleak, and other
clinical conditions that might have prompted postoperative
imaging. As such, we cannot determine if surveillance gaps,
as deﬁned by the SVS guidelines, were based on clinical pa-
rameters or were simply a consequence of poor follow-up.
Furthermore, administrative data may be subject to er-
rors or variability in coding that would skew our results.19
However, coding errors are unlikely for hospitalizations
involving serious medical conditions or major surgical pro-
cedures, or both, such as EVAR.20,21 In addition, previous
work has validated the use of Medicare data as a useful tool
for capturing AAA treatment procedures.22 Moreover,
although our data set is limited in that only Medicare ben-
eﬁciaries are included, it may be most suitable for studying
AAA and EVAR because >70% of elective AAA repairs are
among the U.S. Medicare population.23
CONCLUSIONS
Postoperative imaging after EVAR is highly variable in
the Medicare population, and less than half of patients
meet current surveillance guidelines. Although a few
single-institutional studies have not shown improved out-
comes with complete surveillance,6,8 additional larger
studies are necessary to determine if variability in postoper-
ative surveillance affects long-term outcomes in the Medi-
care population.
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